Literature DB >> 34157819

A Novel Analytical Method for the Simultaneous Estimation of Remogliflozin and Metformin Hydrochloride by UPLC/PDA in Bulk and Formulation Application to the Estimation of Product Traces

Mohan Rao Tammisetty1, Balasekhara Reddy Challa2, Srinivasa Babu Puttagunta3.   

Abstract

Objectives: A selective and novel method has been optimized for the evaluation of remogliflozin and metformin hydrochloride in bulk and in the formulation and cleaning of samples by UPLC-PDA in bulk and formulation and product traces. Materials and
Methods: The principle analytes were eluted with phosphate buffer (pH: 4.5): acetonitrile (60:40%, v/v) as the mobile phase using the Spherisorb C18, 5 μm, 4.6 mm x 150 mm analytical column with a 1.0 mL/min flow rate and a 10 μL sample volume at 245 nm in a photodiode array detector.
Results: The retention times of remogliflozin and metformin hydrochloride were 3.017 min and 5.011 min with a total run time of 8 min. The curve indicates that the correlation coefficient (r2) was superior with a value of 1.000 in the linear range of 10 ng/mL-100.0 ng/mL for remogliflozin and 50 ng/mL-500.0 ng/mL for metformin hydrochloride. The correlation coefficient (r2) for metformin hydrochloride was found to be 1.000. The lower limits of quantification and detection for remogliflozin and metformin hydrochloride were found to be 10 ng/mL and 50 ng/mL, and 5 ng/mL and 10 ng/mL, respectively.
Conclusion: The developed method was validated and applied to the bulk drug estimation and drug formulation and cleaning samples. All the results obtained with this method was accurate and precise.

Entities:  

Keywords:  Remogliflozin; UPLC-PDA; bulk drug; cleaning samples; formulation; metformin hydrochloride

Year:  2021        PMID: 34157819      PMCID: PMC8231326          DOI: 10.4274/tjps.galenos.2020.39699

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  5 in total

1.  Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation.

Authors:  Bassam M Ayoub
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2016-06-06       Impact factor: 4.098

2.  Comparative study between UHPLC-UV and UPLC-MS/MS methods for determination of alogliptin and metformin in their pharmaceutical combination.

Authors:  S Mowaka; B M Ayoub
Journal:  Pharmazie       Date:  2017-02-01       Impact factor: 1.267

3.  Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.

Authors:  Elizabeth K Hussey; Anita Kapur; Robin O'Connor-Semmes; Wenli Tao; Bryan Rafferty; Joseph W Polli; Charles D James; Robert L Dobbins
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-30       Impact factor: 2.483

4.  Development and validation of the liquid chromatographic method for simultaneous estimation of metformin, pioglitazone, and glimepiride in pharmaceutical dosage forms.

Authors:  Vinay Pandit; Roopa S Pai; Kshama Devi; Gurinder Singh; Satya Narayana; Sarasija Suresh
Journal:  Pharm Methods       Date:  2012-01

5.  Comparative Liquid Chromatographic Study for Concurrent Determination of Canagliflozin and Metformin in Combined Tablets.

Authors:  Wafaa A Zaghary; Shereen Mowaka; Moataz S Hendy
Journal:  J Anal Methods Chem       Date:  2017-12-03       Impact factor: 2.193

  5 in total
  3 in total

1.  Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations

Authors:  Nandeesha Itigimatha; Kailash S Chadchan; Basappa C Yallur; Manjunatha D Hadagali
Journal:  Turk J Pharm Sci       Date:  2022-04-29

2.  An Experimental Design Approach to Quantitative Expression for Quality Control of a Multicomponent Antidiabetic Formulation by the HILIC Method.

Authors:  Mahesh Attimarad; Katharigatta Narayanaswamy Venugopala; Muhammad S Chohan; Marysheela David; Efren Ii Plaza Molina; Nagaraja Sreeharsha; Anroop Balachandran Nair; Christophe Tratrat; Abdulrahman Ibrahim Altaysan; Abdulmalek Ahmed Balgoname
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

3.  Development of Ecofriendly Derivative Spectrophotometric Methods for the Simultaneous Quantitative Analysis of Remogliflozin and Vildagliptin from Formulation.

Authors:  Mahesh Attimarad; Katharigatta N Venugopala; Bandar E Al-Dhubiab; Rafea Elamin Elgack Elgorashe; Sheeba Shafi
Journal:  Molecules       Date:  2021-10-12       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.